Today: 7 March 2026

Shan Ahmed Khan

As a journalist focused on finance and the stock market, he delivers fast, reliable, and easy-to-understand coverage of market news.

Dillard’s (DDS) Stock Today: Special Dividend Fallout, Q3 Results, and the Latest Analyst Forecasts (Dec. 16, 2025)

Dillard’s (DDS) Stock Today: Special Dividend Fallout, Q3 Results, and the Latest Analyst Forecasts (Dec. 16, 2025)

Dillard’s stock fell 4.9% Tuesday to $645.61 after hitting an all-time high near $742 on Dec. 11, 2025. The drop follows a surge driven by a $30 special dividend, payable Jan. 5 to holders as of Dec. 12. In Q3, Dillard’s reported net sales of $1.469 billion and net income of $129.8 million, both up from a year earlier.
ABIVAX Société Anonyme (ABVX) Stock News on Dec. 16, 2025: Shares Slide After Q3 Loss Widens, While Analysts Keep Buy Calls and M&A Talk Lingers

ABIVAX Société Anonyme (ABVX) Stock News on Dec. 16, 2025: Shares Slide After Q3 Loss Widens, While Analysts Keep Buy Calls and M&A Talk Lingers

Abivax shares fell about 5% in U.S. and Paris trading after reporting a nine-month net loss of €254.1 million, up from €136.9 million a year earlier. Cash and cash equivalents stood at €589.7 million as of September 30, expected to fund operations into Q4 2027. Investors weighed widening losses against a strong cash position and ongoing takeover speculation.
Booz Allen Hamilton Stock (BAH) Slides on CFO Exit News: Today’s Price Move, Analyst Forecasts, and What Investors Are Watching (Dec. 16, 2025)

Booz Allen Hamilton Stock (BAH) Slides on CFO Exit News: Today’s Price Move, Analyst Forecasts, and What Investors Are Watching (Dec. 16, 2025)

Booz Allen Hamilton shares fell about 8% to $84 Tuesday after CFO Matthew Calderone announced he will resign effective February 1, 2026. The move comes as the company faces a slowdown in parts of its government business and investors weigh its revised fiscal 2026 outlook. Calderone will join S&P Global Mobility as CFO by March 2026. Kristine Martin Anderson will serve as interim CFO.
16 December 2025
Liberty Energy (LBRT) Stock Slides on Dec. 16, 2025 as Oil Drops Below $60 — Latest News, Analyst Forecasts, and What Investors Are Watching

Liberty Energy (LBRT) Stock Slides on Dec. 16, 2025 as Oil Drops Below $60 — Latest News, Analyst Forecasts, and What Investors Are Watching

Liberty Energy Inc. shares fell 8.15% to $17.57 by early afternoon Tuesday after crude oil prices dropped below $60. The stock swung between $19.18 and $17.435 as energy equities broadly declined. Oil prices slid on optimism over Russia–Ukraine peace talks and weak economic data from China. UBS maintained a Buy rating on LBRT, citing its expanding distributed power strategy.
Cipher Mining (CIFR) Stock News Today: Price Action, Analyst Forecasts, and What’s Driving Volatility on Dec. 16, 2025

Cipher Mining (CIFR) Stock News Today: Price Action, Analyst Forecasts, and What’s Driving Volatility on Dec. 16, 2025

Cipher Mining Inc. (NASDAQ: CIFR) closed at $14.13 Tuesday, down 4.17%, after a 13.5% drop Monday tied to Bitcoin weakness and AI sector jitters. Zacks called the stock a “Hold” after a 297% six-month surge, citing projected 2025–26 losses and heavy capex. Benzinga flagged unusual options activity, with traders betting on wide price swings between $10 and $30.
16 December 2025
GeneDx (WGS) Stock Slides on Dec. 16, 2025: Latest News, Analyst Forecasts, and What Investors Are Watching Next

GeneDx (WGS) Stock Slides on Dec. 16, 2025: Latest News, Analyst Forecasts, and What Investors Are Watching Next

GeneDx Holdings shares fell nearly 7% to around $140 intraday Tuesday after closing near $150.6. Trading volume was below average, with no major news driving the drop. The move followed a recent JAMA recognition for the company’s GUARDIAN newborn genomic screening study and several analyst price target hikes earlier in the week. Broader U.S. markets were also under pressure.
16 December 2025
Valaris Limited Stock (NYSE: VAL) Slides on Dec. 16, 2025 as Shell Brazil Deal, Backlog, and Analyst Targets Come Into Focus

Valaris Limited Stock (NYSE: VAL) Slides on Dec. 16, 2025 as Shell Brazil Deal, Backlog, and Analyst Targets Come Into Focus

Valaris shares fell about 8% Tuesday, trading in the high-$40s after a multi-year drillship contract award from Shell offshore Brazil. The contract, announced Dec. 11, is valued at roughly $300 million and starts in 2027. The stock remains well above its 52-week low but is down sharply from recent highs. No single negative headline drove the selloff.
16 December 2025
Oceaneering International (OII) Stock News Today: Why Shares Fell on Dec. 16, 2025 — Forecasts, Analyst Targets, and What Investors Are Watching

Oceaneering International (OII) Stock News Today: Why Shares Fell on Dec. 16, 2025 — Forecasts, Analyst Targets, and What Investors Are Watching

Oceaneering International shares fell about 6.4% to $24.21 in afternoon trading Tuesday, extending a recent decline from the high-$27 range earlier in December. The drop followed a cautious “Hold” consensus from analysts and company guidance pointing to 2026 growth in its defense segment, with early-year weakness expected in energy markets. Trading volume was below average.
16 December 2025
Corcept Therapeutics (CORT) Stock Drops on Dec. 16, 2025: UBS Neutral Call, Relacorilant FDA Catalyst, and Updated Price Targets

Corcept Therapeutics (CORT) Stock Drops on Dec. 16, 2025: UBS Neutral Call, Relacorilant FDA Catalyst, and Updated Price Targets

Corcept Therapeutics shares fell 9% to $79.44 on December 16, 2025, after UBS initiated coverage at Neutral with a $95 target, citing valuation concerns. The stock had surged about 75% year-to-date. No major clinical or regulatory news drove the drop. Trading volume reached approximately 1.27 million shares.
PBF Energy Stock Slides on Refinery Headlines: Today’s News, Analyst Forecasts, and Outlook for NYSE:PBF (December 16, 2025)

PBF Energy Stock Slides on Refinery Headlines: Today’s News, Analyst Forecasts, and Outlook for NYSE:PBF (December 16, 2025)

PBF Energy shares fell about 9% to $27.13 Tuesday after a fire at its Torrance, California refinery and new regulatory scrutiny at its Delaware City plant. The Torrance incident was contained Sunday, but traders cited ongoing operational and compliance risks. Reports highlighted recent emissions violations and new monitoring mandates in Delaware.
16 December 2025
Sanmina Stock (SANM) Slumps on Dec. 16, 2025 After Houston Energy Factory Expansion and Končar Transformer Deal

Sanmina Stock (SANM) Slumps on Dec. 16, 2025 After Houston Energy Factory Expansion and Končar Transformer Deal

Sanmina shares fell 8.85% to $144.17 Tuesday after the company announced plans for a new Houston factory focused on power-grid equipment and a transformer co-design deal with Croatia’s Končar Group. The stock drop followed concerns about capital spending and cash flow, as production at the new facility is not expected to begin until 2027.
16 December 2025
Navan (NAVN) Stock Sinks on Q3 Earnings and CFO Exit: Guidance, Analyst Price Targets, and Forecasts for 2026 (Dec. 16, 2025)

Navan (NAVN) Stock Sinks on Q3 Earnings and CFO Exit: Guidance, Analyst Price Targets, and Forecasts for 2026 (Dec. 16, 2025)

Navan shares fell 17%–18% by midday Tuesday after the company reported a larger-than-expected GAAP net loss and announced CFO Amy Butte will step down January 9, 2026. The stock has dropped over 40% since its IPO, cutting market value below $3 billion. Q3 revenue rose 29% to $195 million, but GAAP net loss reached $225 million, driven by $103 million in stock-based compensation and a $97 million debt extinguishment charge.
16 December 2025
Arrowhead Pharmaceuticals (ARWR) Stock Drops on Dec. 16, 2025: Latest News, Analyst Forecasts, and What Investors Are Watching

Arrowhead Pharmaceuticals (ARWR) Stock Drops on Dec. 16, 2025: Latest News, Analyst Forecasts, and What Investors Are Watching

Arrowhead Pharmaceuticals shares fell about 9% Tuesday, trading near $62 after touching an intraday low of $59.76. The decline follows a recent surge to a 52-week high after FDA approval of its first drug, REDEMPLO, and an FDA Breakthrough Therapy designation. No single negative catalyst was cited; analysts pointed to profit-taking and volatility after recent gains. Arrowhead also disclosed routine equity grants for new hires.
Compass Inc stock COMP: Latest news, analyst forecasts, and key catalysts on December 16 2025

Compass Inc stock COMP: Latest news, analyst forecasts, and key catalysts on December 16 2025

Compass Inc shares rebounded to $10.76 by midday Tuesday after dropping on news that Google is testing home listing features in search results. Trading volume topped 2.3 million shares. Monday’s selloff followed reports of Google’s pilot in select cities, sparking fears of new competition in online real estate. Investors appeared to reassess the immediate threat by Tuesday’s session.
16 December 2025
Vertex, Inc. (VERX) Stock News Today: Latest Price, AI Tax Automation Updates, Analyst Forecasts and Outlook (Dec. 16, 2025)

Vertex, Inc. (VERX) Stock News Today: Latest Price, AI Tax Automation Updates, Analyst Forecasts and Outlook (Dec. 16, 2025)

Vertex, Inc. (NASDAQ: VERX) shares rose about 5% to $20.48 intraday Tuesday, trading higher amid ongoing cloud migration and an AI-driven product push. The stock has hovered in the $19–$20 range for weeks, with recent gains following the October launch of “Kintsugi powered by Vertex,” an AI tax automation tool targeting SMBs. Management has flagged slower expansion from existing customers despite double-digit revenue growth.
16 December 2025
Comcast Stock (CMCSA) Jumps on Activist Chatter as Versant Spinoff Record Date Arrives — News, Forecasts, and What Investors Are Watching

Comcast Stock (CMCSA) Jumps on Activist Chatter as Versant Spinoff Record Date Arrives — News, Forecasts, and What Investors Are Watching

Comcast shares jumped 4.3% to $29.43 on December 16, 2025, amid heavy trading and speculation about activist investor involvement. The move coincided with the record date for Comcast’s Versant Media Group spin-off, which will distribute Versant shares to eligible holders in early January. No activist investor has been publicly identified.
1 438 439 440 441 442 584
Go toTop